Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Revolution Medicines Inc shares valued at $79,525 were purchased by JEFFREY TODD CISLINI on Sep 24 ’25. At $44.21 per share, JEFFREY TODD CISLINI acquired 1,799 shares.
Also, Wei Lin sold 2,160 shares, netting a total of over 98,982 in proceeds. Following the sale of shares at $45.82 each, the insider now holds 88,339 shares.
Before that, Kelsey Stephen Michael had sold 5,367 shares from its account. In a trade valued at $245,942, the insider traded Revolution Medicines Inc shares for $45.82 each. Upon closing the transaction, the insider’s holdings decreased to 5,367 shares, worth approximately $12.07 million.
Analysts at Truist started covering the stock with ‘”a Buy”‘ outlook in a report released in early September. As of August 19, 2025, Piper Sandler has initiated its “an Overweight” rating for RVMD. Earlier on August 15, 2025, Wells Fargo initiated its rating. Their recommendation was “an Overweight” for RVMD stock.
Analyzing RVMD Stock Performance
On last trading session, Revolution Medicines Inc [NASDAQ: RVMD] plunged -2.37% to $42.51. The stock’s lowest price that day was $42.18, but it reached a high of $43.59 in the same session. During the last five days, there has been a drop of approximately -5.99%. Over the course of the year, Revolution Medicines Inc shares have dropped approximately -0.28%. Shares of the company reached a 52-week high of $47.21 on 09/15/25 and a 52-week low of $29.17 on 04/07/25.
Support And Resistance Levels for Revolution Medicines Inc (RVMD)
According to the 24-hour chart, there is a support level at 41.93, which, if violated, would cause prices to drop to 41.35. In the upper region, resistance lies at 43.34. The next price resistance is at 44.17. RSI (Relative Strength Index) is 53.27 on the 14-day chart, showing neutral technical sentiment.
Is Revolution Medicines Inc subject to short interest?
Stocks of Revolution Medicines Inc saw a sharp rise in short interest on 2025-08-29 jumping by 2.6 million shares to 16.53 million. Data from Yahoo Finance shows that the short interest on 2025-07-31 was 13.93 million shares. A jump of 15.71% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 8.49 of the overall float, the days-to-cover ratio (short ratio) jumped to 8.49.
Which companies own the most shares of Revolution Medicines Inc (RVMD)?
In terms of Revolution Medicines Inc share price expectations, FactSet research, analysts set an average price target of 73.5 in the next 12 months, up nearly 68.81% from the previous closing price of $43.54. Analysts anticipate Revolution Medicines Inc stock to reach 99 by 2025, with the lowest price target being 64. In spite of this, 13 analysts ranked Revolution Medicines Inc stock as Buy at the end of 2025. On July 15, 2025, Goldman assigned a price target of “a Buy” to the stock and initiated coverage with a $65.
